Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference42 articles.
1. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients;McCluskey;Ophthalmology,1999
2. Ocular manifestations of Wegener's granulomatosis;Taylor;Expert Rev Ophthalmol,2007
3. Characterization of a human B lymphocyte-specific antigen;Stashenko;J Immunol,1980
4. Effective therapeutic use of rituximab in refractory Wegener's granulomatosis;Ferraro;Nephrol Dial Transplant,2005
5. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis;Keogh;Arthritis Rheum,2005
Cited by 164 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of Rituximab on Refractory Organ Involvements in Granulomatosis with Polyangiitis: A Systematic Review of Case Reports;Current Rheumatology Reviews;2024-07
2. Effectiveness of difluprednate in addition to systemic therapy for the treatment of anterior scleritis;British Journal of Ophthalmology;2023-09-04
3. Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring;Ocular Immunology and Inflammation;2023-07-12
4. Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis;Autoimmunity Reviews;2023-03
5. Induction failure in granulomatosis with polyangiitis: a nationwide case-control study of risk factors and outcomes;Rheumatology;2023-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3